Dopamine and schizophrenia.
D000662:Amphetamines / Q000506:poisoning; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D009474:Neurons / Q000502:physiology; D011388:Prolactin / Q000378:metabolism; D011605:Psychoses, Substance-Induced / Q000209:etiology; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D013997:Time Factors
D000662:Amphetamines; D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D011388:Prolactin; D005968:Glutamate Decarboxylase; D004298:Dopamine; D006719:Homovanillic Acid